| Autor: |
Ash RB; The Center for Cancer Prevention and Treatment, St. Joseph Hospital, Orange, California, USA., Williams VL, Wagman LD, Forouzannia A |
| Jazyk: |
angličtina |
| Zdroj: |
Oncology (Williston Park, N.Y.) [Oncology (Williston Park)] 2013 Feb; Vol. 27 (2), pp. 107-13. |
| Abstrakt: |
Over one-quarter of a million cases of breast cancer are diagnosed in the United States each year, many of which are early stage.The radiotherapeutic options after breast-conserving surgery in early-stage breast cancer are evolving quickly, with a focus on minimizing treatment volume, toxicity, and treatment duration. One such emerging option is intraoperative radiotherapy (IORT), administered either as a single fraction or as a boost.With many centers seeking to adopt such technology, there are licensing, proctoring, staffing, technical support, and reimbursement issues that need to be considered. We have reviewed the current international experience and describe one community cancer center's experience with initiating an IORT breast cancer program. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
